These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9552410)

  • 1. Contribution of the dual coding capacity of the p16INK4a/MTS1/CDKN2 locus to human malignancies.
    Larsen CJ
    Prog Cell Cycle Res; 1997; 3():109-24. PubMed ID: 9552410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
    Larsen CJ
    Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of murine p16INK4a and p15INK4b genes.
    Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M
    Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
    Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene.
    Della Valle V; Duro D; Bernard O; Larsen CJ
    Oncogene; 1997 Nov; 15(20):2475-81. PubMed ID: 9395243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
    Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
    Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines.
    Zhou X; Suzuki H; Shimada Y; Imamura M; Yin J; Jiang HY; Tarmin L; Abraham JM; Meltzer SJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):285-90. PubMed ID: 7547637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
    Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
    Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
    Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma.
    Siebert R; Willers CP; Opalka B
    Leuk Lymphoma; 1996 Nov; 23(5-6):505-20. PubMed ID: 9031081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
    Zhang S; Ramsay ES; Mock BA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2429-34. PubMed ID: 9482902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J; Kratzke RA; Niehans GA; Lincoln CE
    Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
    Quesnel B
    Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN2 (MTS1/p16INK4A) gene alterations in hematological malignancies.
    Uchida T; Kinoshita T; Saito H; Hotta T
    Leuk Lymphoma; 1997 Feb; 24(5-6):449-61. PubMed ID: 9086436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor protein p16INK4a.
    Serrano M
    Exp Cell Res; 1997 Nov; 237(1):7-13. PubMed ID: 9417860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.